Gressler Laura, Lewis Kanna
Division of Pharmaceutical Evaluation and Policy, Department of Pharmacy Practice, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Department of Family and Preventive Medicine, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham #530, Little Rock, AR, 72205, USA.
BMC Public Health. 2025 Jul 2;25(1):2265. doi: 10.1186/s12889-025-23468-8.
The Supreme Court's decision in Dobbs v. Jackson Women's Health Organization overturned the Roe v. Wade precedent, significantly altering abortion access across the United States (U.S.). This ruling enabled states to regulate, limit, or ban abortion, resulting in millions of women losing access to abortion services and potentially affecting birth outcomes. This study aimed to assess the impact of the Dobbs decision on birth outcomes in states with and without abortion bans.
A retrospective cohort analysis applied comparative interrupted time series to assess the difference in changes in adverse birth outcomes pre-and post-Dobbs across abortion legislation status. Natality data from the CDC WONDER database was analyzed. States were classified based on the presence or absence of abortion bans as of June 24, 2022. Proportions of non-living births, births with congenital anomalies, and maternal morbidities among U.S. births between January 2021 and February 2024 were examined.
No statistically significant difference in non-living births was observed between states with and without abortion bans. In states with abortion bans, the rate of births with congenital anomalies increased slightly post-Dobbs but the increase was not statistically significant. States without bans saw a decrease of 2 per 10,000 births (p < 0.001) from the baseline. The difference in the change in congenital anomalies between states with and without bans was 4.3 per 10,000 births (p = 0.015). States with abortion bans did not experience significant changes in maternal morbidity rates post-Dobbs, while states without bans experienced an increase of 4.8 per 10,000 births (p < 0.001). The difference between the changes in maternal morbidity rates was 4.5 per 10,000 births (p = 0.014).
The Dobbs decision has led to divergent birth outcomes in states with and without abortion bans. States without bans experienced a decrease in congenital anomalies and an increase in maternal morbidity rates, while the proportion of these adverse birth outcomes were unchanging in states with bans. Although a direct evidence of abortion bans increasing adverse birth outcomes was not found, the difference in the changes in congenital anomalies across abortion policies suggests that there is a potential for the exacerbation of inequities and further investigation is warranted.
美国最高法院在多布斯诉杰克逊妇女健康组织案中的裁决推翻了罗诉韦德案的先例,极大地改变了美国各地的堕胎服务可及性。这一裁决使各州能够对堕胎进行监管、限制或禁止,导致数百万妇女无法获得堕胎服务,并可能影响生育结果。本研究旨在评估多布斯裁决对有堕胎禁令和无堕胎禁令各州生育结果的影响。
一项回顾性队列分析采用比较间断时间序列,以评估多布斯裁决前后不同堕胎立法状态下不良生育结果变化的差异。分析了疾病控制与预防中心(CDC)WONDER数据库中的出生数据。根据截至2022年6月24日是否存在堕胎禁令对各州进行分类。研究了2021年1月至2024年2月美国出生人口中死产、先天性异常出生以及孕产妇发病的比例。
有堕胎禁令和无堕胎禁令的州之间,死产情况未观察到统计学上的显著差异。在有堕胎禁令的州,多布斯裁决后先天性异常出生的比例略有上升,但增幅无统计学意义。无堕胎禁令的州每10000例出生中该比例较基线下降了2例(p<0.001)。有堕胎禁令和无堕胎禁令的州之间先天性异常变化的差异为每10000例出生4.3例(p=0.015)。有堕胎禁令的州在多布斯裁决后孕产妇发病率没有显著变化,而无堕胎禁令的州每10000例出生中发病率增加了4.8例(p<0.001)。孕产妇发病率变化的差异为每10000例出生4.5例(p=0.014)。
多布斯裁决导致有堕胎禁令和无堕胎禁令的州出现了不同的生育结果。无堕胎禁令的州先天性异常出生比例下降,孕产妇发病率上升,而有堕胎禁令的州这些不良生育结果的比例没有变化。虽然未发现堕胎禁令增加不良生育结果的直接证据,但不同堕胎政策下先天性异常变化的差异表明存在不平等加剧的可能性,值得进一步调查。